×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Session 0504: PRECLINICAL DMPK: BUILDING QUALITY DATA AND SYSTEM
Session Chair(s)
Representative Invited
WHO, India
Drug metabolism and Pharmacokinetics (DMPK) has played a critical role in drug discovery and development. How to get quality data and build a quality system for research and preclinical DMPK is essential for the China pharmaceutical industry. This session will start with using quality animals for in vivo PK/safety studies and building a quality system for bioanalysis. It will then discuss the importance of quality PK data for anti-body drug conjugate (ADC) drug development.
Speaker(s)
The Importance of the Quality of Animals in Conducting Tox/DMPK Studies
Kobe Liu
GlaxoSmithKline R&D Shanghai, China
Building a Quality Program for Bioanalysis
JinSong Xing
Wuxi AppTec, China
Yuanguo Cheng
Academy of Military Medical Science, China
Have an account?